Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News

Cinctive Capital Management LP Buys Shares of 14,760 BioNTech SE (NASDAQ:BNTX)

Is BioNTech SE (BNTX) the Best German Stock to Buy According to Hedge Funds?

BioNTech (NASDAQ:BNTX) Price Target Cut to $145.00 by Analysts at HC Wainwright

Groupama Asset Managment Buys 19,994 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE (NASDAQ:BNTX) Receives Consensus Rating of "Moderate Buy" from Brokerages

BioNTech (NASDAQ:BNTX) Shares Gap Down - Time to Sell?

Analysts' Top Healthcare Picks: Ascentage Pharma Group International Unsponsored ADR (AAPG), BioNTech SE (BNTX) | Markets Insider

Mitsubishi UFJ Trust & Banking Corp Has $21.37 Million Position in BioNTech SE (NASDAQ:BNTX)

CureVac (CVAC) Rises 10% After Key Patent Victory; Other Movers

European Patent Office declares CureVac mRNA patent valid

CureVac (CVAC) Surges as European Court Validates Key Patent

CORRECT: CureVac Says Patent Validated in Dispute With BioNTech

Is BioNTech SE (BNTX) a Promising Biotech Stock According to Wall Street Analysts

Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2024 Earnings Call Transcript

Autolus Therapeutics PLC (AUTL) Q4 2024 Earnings Call Highlights: Financial Growth Amid Rising Costs

BioNTech SE (NASDAQ:BNTX) Shares Sold by Primecap Management Co. CA

Morgan Stanley Keeps Their Buy Rating on BioNTech SE (BNTX) | Markets Insider

Gallacher Capital Management LLC Sells 159 Shares of BioNTech SE (NASDAQ:BNTX)
BioNTech SE (NASDAQ:BNTX) Analysts Just Slashed This Year's Estimates

Vestcor Inc Has $1.13 Million Stake in BioNTech SE (NASDAQ:BNTX)

BioNTech (NASDAQ:BNTX) Now Covered by Citigroup

Lbp Am Sa Buys 5,085 Shares of BioNTech SE (NASDAQ:BNTX)

Lbp Am Sa Purchases 5,085 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech (NASDAQ:BNTX) Now Covered by Analysts at Citigroup

BioNTech SE (NASDAQ:BNTX) Receives $142.72 Consensus PT from Analysts

This biotech stock is a buy thanks to its cancer treatment pipeline, Citi says

BioNTech initiated with a Buy at Citi | Markets Insider

Amundi Sells 85,658 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech (NASDAQ:BNTX) Trading Down 6.4% Following Analyst Downgrade

BioNTech (NASDAQ:BNTX) Given "Buy" Rating at Canaccord Genuity Group

BMO Capital Markets Issues Positive Forecast for BioNTech (NASDAQ:BNTX) Stock Price

BioNTech (NASDAQ:BNTX) Issues Quarterly Earnings Results, Beats Estimates By $0.70 EPS

HC Wainwright Predicts BioNTech FY2024 Earnings

BioNTech (BNTX) Expected to Announce Earnings on Wednesday

BioNTech price target lowered to $151 from $172 at Truist | Markets Insider

Goldman Sachs Sticks to Its Buy Rating for BioNTech SE (BNTX) | Markets Insider

BioNTech price target lowered to $110 from $122 at TD Cowen | Markets Insider

BioNTech SE (NASDAQ:BNTX) Q4 2024 Earnings Call Transcript

BioNTech price target raised to $143 from $130 at BMO Capital | Markets Insider

BioNTech Earnings: 2025 Guidance Disappoints, Fair Value Lowered | Morningstar

BioNTech's mRNA Technology and Acquired Oncology Programs Could Support a Future Moat | Morningstar

Analysts Have Conflicting Sentiments on These Healthcare Companies: BioNTech SE (BNTX) and Trevi Therapeutics (TRVI) | Markets Insider

BioNTech price target lowered to $143 from $147 at BofA | Markets Insider

German Court Rules Pfizer, BioNTech Infringed Moderna's COVID-19 Vaccine Patent

BNTX Earnings: BioNTech Stock Slips Despite Q4 Beats | Markets Insider

Morgan Stanley Remains a Buy on BioNTech SE (BNTX) | Markets Insider

BioNTech (NASDAQ:BNTX) Releases Earnings Results, Beats Expectations By $0.70 EPS

BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update | The Manila Times

BioNTech reports Q4 EPS EUR 1.08 vs. EUR 1.88 last year | Markets Insider

BioNTech sees FY25 CapEx EUR 250M-EUR 350M | Markets Insider

BioNTech sees FY25 revenue EUR 1.7B-EUR 2.2B | Markets Insider

1,200 Shares in BioNTech SE (NASDAQ:BNTX) Purchased by Generali Investments CEE investicni spolecnost a.s.

BioNTech Warns On FY25 Revenues After Weak Q4; Stock Dips

BioNTech SE Q4 Income Retreats, But Beats Estimates

Amended: BioNTech SE Q4 Income Declines

BioNTech SE Q4 24 Earnings Conference Call At 8:00 AM ET
Latest news

Stock market today: Most Asian stocks fell after US equities declined

MicroStrategy joins Nasdaq-100 index: MSTR stock performance analysis 2024

Morning Note: Tesla Soars, AUDUSD Hits Key Support, Oil & SP500 Insights

Nikkei 225 up 1.39%: Japanese Stocks Rise Following Yen's Continued Weakness